Sue Harnan
Overview
Explore the profile of Sue Harnan including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
23
Citations
218
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Cooper K, Nalbant G, Essat M, Harnan S, Wong R, Hamilton J, et al.
Breast Cancer Res Treat
. 2025 Feb;
PMID: 39899163
Purpose: To systematically review the effectiveness of gene expression profiling tests to inform adjuvant chemotherapy decisions in people with hormone receptor-positive (HR+), lymph node-positive (LN+) breast cancer. Methods: This systematic...
2.
Harnan S, Hamilton J, Simpson E, Clowes M, Biz A, Whyte S, et al.
Colorectal Dis
. 2024 Dec;
PMID: 39690130
Aim: Extending faecal immunochemical tests for haemoglobin (FIT) to all primary care patients with symptoms suggestive of colorectal cancer (CRC) could identify people who are likely to benefit from colonoscopy...
3.
Woods B, Kearns B, Schmitt L, Jankovic D, Rothery C, Harnan S, et al.
Appl Health Econ Health Policy
. 2024 Nov;
23(1):5-17.
PMID: 39616299
Objectives: The UK has recently established subscription-payment agreements for two antimicrobials: cefiderocol and ceftazidime-avibactam. This article summarises the novel value assessments that informed this process and lessons learned for future...
4.
Harnan S, Kearns B, Scope A, Schmitt L, Jankovic D, Hamilton J, et al.
Health Technol Assess
. 2024 Nov;
28(73):1-230.
PMID: 39487661
Background: To limit the use of antimicrobials without disincentivising the development of novel antimicrobials, there is interest in establishing innovative models that fund antimicrobials based on an evaluation of their...
5.
Cooper K, Nalbant G, Sutton A, Harnan S, Thokala P, Chilcott J, et al.
Int J Neonatal Screen
. 2024 Aug;
10(3).
PMID: 39189228
Spinal muscular atrophy (SMA) causes the degeneration of motor neurons in the spinal cord. Treatments including nusinersen, risdiplam, and onasemnogene abeparvovec have been shown to be effective in reducing symptoms,...
6.
Cooper K, Nalbant G, Sutton A, Harnan S, Thokala P, Chilcott J, et al.
Int J Neonatal Screen
. 2024 Jul;
10(3).
PMID: 39051405
Spinal muscular atrophy (SMA) is a genetic neuromuscular disorder causing the degeneration of motor neurons in the spinal cord. Recent studies suggest greater effectiveness of treatment in the presymptomatic stage....
7.
Woods B, Schmitt L, Jankovic D, Kearns B, Scope A, Ren S, et al.
Health Technol Assess
. 2024 Jun;
28(28):1-238.
PMID: 38938145
Background: To limit the use of antimicrobials without disincentivising the development of novel antimicrobials, there is interest in establishing innovative models that fund antimicrobials based on an evaluation of their...
8.
Cooper K, Campbell F, Harnan S, Sutton A
Compr Psychoneuroendocrinol
. 2023 Dec;
16:100215.
PMID: 38108025
Background: Several studies have suggested links between psychological stress, depression or anxiety, and cancer incidence or outcomes. Existing systematic reviews have addressed this question, with differing results. Aims: This rapid...
9.
Poku E, Cooper K, Cantrell A, Harnan S, Abu Sin M, Zanuzdana A, et al.
JAC Antimicrob Resist
. 2023 Jan;
5(1):dlad001.
PMID: 36694849
Background: Antimicrobial resistance (AMR) causes substantial health and economic burden to individuals, healthcare systems and societies globally. Understanding the temporal relationship between antibiotic consumption and antibiotic resistance in hospitalized patients...
10.
Poku E, Harnan S, Rooney G, Martyn-St James M, Hernandez-Alava M, Schaufler T, et al.
Clin Kidney J
. 2022 Feb;
15(3):484-499.
PMID: 35211305
Background: Chronic kidney disease-associated pruritus (CKD-aP) is a common and burdensome condition for end-stage kidney disease (ESKD) patients, especially those receiving haemodialysis. High-quality evidence of the relationship between CKD-aP and...